Clinical Trial Update: A Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, in Subjects With Advanced Tumors. [Phase 1]

View source ↗

Summary

This clinical trial update reports results from a Phase 1 dose-escalation and dose-expansion study evaluating the safety, tolerability, and antitumor activity o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• MEDI-575

Snippet

Sponsor: MedImmune LLC | Conditions: Cancer | Phase 1 | Status: COMPLETED | Results posted: 2017-04-11